Defence Therapeutics Inc.
Defence Therapeutics Inc.
CSE Index:
Currency:
Defence Therapeutics Inc. is a biotechnology company engaged in the business of research and development, focusing on enhancing delivery of tumor-/ and infectious disease-specific therapeutics. The principal business carried on is the development of a biological drug enhancer platform that improves the efficacy and safety of a multitude of biological/biosimilar-based pharmaceuticals used in the treatment of cancer and infectious diseases.
Defence Therapeutics Inc. (DTC)
SEDAR Information
Company Info
Address
1680, 200 Burrard St.
Vancouver, BC V6C 3L6
CanadaPhone
514-947-2272Email
sebas.plouffe@gmail.comWebsite
https://defencetherapeutics.comListing date
Friday, May 7, 2021Transfer Agent
Computershare Investor Services Inc.Capitalization
Issued & Outstanding:
45536673Reserved for Issuance:
5474260Company Officers
Sébastien Plouffe, Chief Executive Officer
P. Joseph Meagher, Chief Financial Officer
Bulletins
06/05/2021
2021-0505 – New Listing - Defence Therapeutics Inc. (DTC)
Le 6 mai/May 2021
The common shares of Defence Therapeutics Inc., have been approved for listing on the CSE.
Listing and disclosure documents will be available at www.thecse.com on the trading date.
